Table 1.
Estimated cost savings and expenses associated with the AMS program implemented at the four HMG medical facilities between 2016 and 2019
| year | Total antimicrobial expenditures (S.R.) | Patient-Days | ARPD (S.R.)a | Actual savings and expenses compared with 2015 (S.R.)b |
|---|---|---|---|---|
| 2015 | 11,502,287 | 173,297 | 66.37 | |
| 2016 | 8,229,378 | 185,958 | 44.25 | 4,113,261 |
| 2017 | 9,163,568 | 132,150 | 69.34 | - 392,342 |
| 2018 | 7,601,056 | 147,269 | 51.61 | 2,173,668 |
| 2019 | 5,361,239 | 79,075 | 67.79 | - 112,774 |
aARPD = antimicrobial riyals per patient-day
bCalculated by subtracting the year’s ARPD from 2015’s ARPD and multiplying the result by the number of patient-days for the year. Total actual savings and expenses for 2016–2019, S.R. 6,286,929 (high savings) and S.R. 505,115 (low expenses)